We are live on
!
Find out more
AnaptysBio
ANAB
ANAB
207 hedge funds and large institutions have $1.55B invested in AnaptysBio in 2026 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 58 increasing their positions, 70 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
364% more call options, than puts
Call options by funds: $1.41M | Put options by funds: $305K
155% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 20
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
16% more funds holding
Funds holding: 179 → 207 (+28)
9% more capital invested
Capital invested by funds: $1.42B → $1.55B (+$128M)
7.8% less ownership
Funds ownership: 106.02% → 98.22% (-7.8%)
17% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 70
Holders
207
Holders Change
+28
Holders Change %
+15.64%
% of All Funds
2.55%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
51
Increased
58
Reduced
70
Closed
20
Calls
$1.41M
Puts
$305K
Net Calls
+$1.11M
Net Calls Change
+$4.48M
Top Buyers
| 1 |
AAA
Affinity Asset Advisors
New York
|
+$26.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$24M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$19.9M |
| 4 |
SAM
Synergy Asset Management
Vancouver,
Washington
|
+$17.1M |
| 5 |
ACA
Apis Capital Advisors
New York
|
+$12.8M |
